Evidence map›Paper›PMID 33952594›Full record

ArticleJournal of clinical microbiology2021

An Improved Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Data Analysis Pipeline for the Identification of Carbapenemase-Producing Klebsiella pneumoniae.

Eva Gato, Ignacio Pedro Constanso, Ana Candela, Fátima Galán, Bruno Kotska Rodiño-Janeiro, Manuel Jesús Arroyo, Gema Méndez, Luis Mancera, Tyler Alioto, Marta Gut and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Accelerated detection ofMicrobiology spectrum · 2026
    Article
  4. Review
  5. Article
  6. NDM-5-carrying3 Biotech · 2023
    Article
  7. Rapid discrimination ofFrontiers in microbiology · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Eva GatoServicio de Microbiología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Ignacio Pedro ConstansoServicio de Análisis Clínicos, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Ana CandelaServicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Fátima GalánServicio de Microbiología, Hospital Puerta del Mar, Cádiz, Spain.
Bruno Kotska Rodiño-JaneiroServicio de Microbiología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Manuel Jesús ArroyoClover Bioanalytical Software S.L., Granada, Spain.
Gema MéndezClover Bioanalytical Software S.L., Granada, Spain.
Luis ManceraClover Bioanalytical Software S.L., Granada, Spain.
Tyler AliotoCentre for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Marta GutCentre for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Ivo GutCentre for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Miguel Álvarez-TejadoRoche Diagnostics SL, Barcelona, Spain.
Belén Rodríguez-SánchezServicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Germán BouServicio de Microbiología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Marina OviañoServicio de Microbiología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Complexo Hospitalario Universitario A Coruña · ESCentre for Genomic Regulation · ESSoftware (Spain) · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Puerta del Mar · ESRoche (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing emergence of carbapenemase-producing Klebsiella pneumoniae (CPK) isolates is a global health alarm. Rapid methods that require minimum sample preparation and rapid data analysis are urgently required. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has recently been used by clinical laboratories for identification of antibiotic-resistant bacteria; however, discrepancies have arisen regarding biological and technical issues. The aim of this study was to standardize an operating procedure and data analysis for identification of CPK by MALDI-TOF MS. To evaluate this approach, a series of 162 K. pneumoniae isolates (112 CPK and 50 non-CPK) were processed in the MALDI BioTyper system (Bruker Daltonik, Germany) following a standard operating procedure. The study was conducted in two stages; the first is denominated the "reproducibility stage" and the second "CPK identification." The first stage was designed to evaluate the biological and technical variation associated with the entire analysis of CPK and the second stage to assess the final accuracy of MALDI-TOF MS for the identification of CPK. Therefore, we present an improved MALDI-TOF MS data analysis pipeline using neural network analysis implemented in Clover MS Data Analysis Software (Clover Biosoft, Spain) that is designed to reduce variability, guarantee interlaboratory reproducibility, and maximize the information selected from the bacterial proteome. Using the random forest (RF) algorithm, 100% of CPK isolates were correctly identified when all the peaks in the spectra were selected as input features and total ion current (TIC) normalization was applied. Thus, we have demonstrated that real-time direct tracking of CPK is possible using MALDI-TOF MS.

Indexed as

Data AnalysisKlebsiella pneumoniaeBacterial Proteinsbeta-LactamasesGermanyReproducibility of ResultsSpainSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBacterial Proteinsbeta-LactamasescarbapenemasecarbapenemasesKlebsiella pneumoniaeMALDI-TOF

Identifiers

PMID33952594
PMCPMC8218777
OpenAlexW3159164036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.